Low Risk Setup
Astrazenca was underperforming the markets. Recently the stock has taken support at previous pivot low and resistance turned support. Low risk entry available for high risk reward
免责声明
这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。